The EC has approved AstraZeneca's Fasenra as an add-on therapy for adults with r...
South Korea’s Ministry of Health and Welfare recently disclosed its proposal to ...
A mid-phase trial featuring Gilead Sciences and Merck & Co.’s once-weekly HIV co...
The latest research on Arcus Biosciences’ experimental HIF-2a inhibitor suggests...
Marinus Pharmaceuticals, a pharmaceutical company, has been dealt a blow after i...
Two early-phase study trials suggest that GSK’s RSV vaccine, Arexvy, may benefit...
Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at...
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new ...
The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’...
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared pre...
New research casts doubt on current advice recommending AF patients wait up to 1...
The Phase III ECZTEND study reported that patients treated with Adbry demonstrat...
A new vaccines drug substance facility and R&D pilot plant, completed by the end...
The California-based Lyell is expected to pay up to $30m in cash along with shar...
The funds will be used to advance Agomab’s candidates through clinical trials, i...
Dyno has formed a new research partnership with Roche on the development of AAV ...
